北京中医药大学东直门医院,北京 100700
魏兰,女,24岁,硕士研究生。研究方向:中西医结合防治心血管疾病。
张立晶,E-mail:dzmyyccu@163.com
收稿:2024-11-29,
纸质出版:2025-11-25
移动端阅览
魏兰,李蒙,刘碧绒,等.从“毒”论治恶性肿瘤治疗相关的心血管毒性[J].北京中医药,2025,44(11):1478-1482.
WEI Lan,LI Meng,LIU Birong,et al.Treatment of cardiotoxicity caused by the treatment of malignant tumors from the toxicological perspective[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(11):1478-1482.
魏兰,李蒙,刘碧绒,等.从“毒”论治恶性肿瘤治疗相关的心血管毒性[J].北京中医药,2025,44(11):1478-1482. DOI: 10.16025/j.1674-1307.2025.11.021.
WEI Lan,LI Meng,LIU Birong,et al.Treatment of cardiotoxicity caused by the treatment of malignant tumors from the toxicological perspective[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(11):1478-1482. DOI: 10.16025/j.1674-1307.2025.11.021.
目前恶性肿瘤的主要治疗方法为手术、化疗、放疗和靶向治疗等。中医理论认为肿瘤为毒邪积聚的产物,集聚的毒邪作为内毒会消耗正气,导致气血不足,心脉失于濡养;常用的药物和放射线属外毒袭内,治疗过程中常伴随不良反应(骨髓抑制、胃肠道刺激、免疫反应等),其中最严重的是心血管毒性,治疗上应以“扶正透毒”“攻毒散结”为主。
The primary current treatments for malignant tumors include surgery, chemotherapy, radiotherapy, and targeted therapy. According to Traditional Chinese Medicine (TCM) theory, tumors result from the accumulation of pathogenic toxins that consume healthy
qi
, acting as internal toxins. This leads to a deficiency of
qi
and blood, resulting in insufficient nourishment of the heart and vessels. Commonly used drugs and radiation function as external toxins invading the body, and the treatment process is often accompanied by adverse reactions such as bone marrow suppression, gastrointestinal irritation, and immune responses, with cardiovascular toxicity being the most severe. Therefore, treatment should primarily focus on "supporting healthy
qi
and eliminating toxins" as well as "attacking toxins to resolve masses.
RIVIER C , MERY B , ROWINSKI E , et al . Breast cancer treatment-related cardiovascular disturbances: advocacy for a watchful attitude in this never-ending story [J ] . Expert Opin Drug Saf , 2022 , 21 ( 4 ): 453 - 465 .
DONNELLAN E , PHELAN D , MCCARTHY CP , et al . Radiation-induced heart disease: A practical guide to diagnosis and management [J ] . Cleve Clin J Med , 2016 , 83 ( 12 ): 914 - 922 .
ANKER MS , HüLSMANN M , CLELAND JG . What do patients with heart failure die from? A single assassin or a conspiracy [J ] . Eur J Heart Fail , 2020 , 22 ( 1 ): 26 - 28 .
占凯 , 程良斌 . 中医“毒”之浅析 [J ] . 湖北中医药大学学报 , 2017 , 19 ( 1 ): 47 - 50 .
郑红刚 , 朴炳奎 . 浅议放化疗毒副作用的中医病因 [J ] . 中国中医基础医学杂志 , 2007 , 13 ( 10 ): 751 - 752 .
陈玥灿 , 陈信义 , 郎海燕 . 陈信义基于"浊毒病机论"分期辨治恶性淋巴瘤经验撷要 [J ] . 北京中医药 , 2024 , 43 ( 10 ): 1088 - 1091 .
于惠博 , 花宝金 , 郑红刚 , 等 . 花宝金基于"调气解毒"理论防治肝癌的策略与实践 [J ] . 北京中医药 , 2024 , 43 ( 3 ): 292 - 295 .
CLARKE M , COLLINS R , DARBY S , et al . Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials [J ] . Lancet , 2005 , 366 ( 9503 ): 2087 - 2106 .
HUANG RX , ZHOU PK . DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer [J ] . Signal Transduct Target Ther , 2020 , 5 ( 1 ): 60 .
孙军霞 , 李宏亮 . 大分割放疗治疗非小细胞肺癌的疗效观察和毒副作用 [J ] . 沈阳药科大学学报 , 2021 , 38 ( S1 ): 128 .
宋凤丽 , 康宁 , 柯应水 , 等 . 放射性皮肤损伤从“肺热络瘀”论治 [J ] . 中华中医药杂志 , 2017 , 32 ( 2 ): 511 - 513 .
高颖 , 杜磊 , 肖冲 , 等 . 化疗药依托泊苷的中医性能探讨 [J ] . 湖北中医杂志 , 2021 , 43 ( 4 ): 50 - 53 .
张可欣 , 方凤奇 . 乳腺癌靶向治疗的心脏保护:基于《2021CSCO肿瘤治疗相关心血管毒性防治指南》解读 [J ] . 中国临床新医学 , 2022 , 15 ( 6 ): 496 - 500 .
杨宗块 , 梁平 . 抗肿瘤药物心脏毒性及机制探讨 [J ] . 临床军医杂志 , 2022 , 50 ( 3 ): 321 - 324 .
黄小玲 , 林久茂 , 陈武进 . 中医药治疗恶性肿瘤靶向药物所致不良反应概述 [J ] . 中国民间疗法 , 2021 , 29 ( 2 ): 113 - 117 .
BHAGAT A , KLEINERMAN ES . Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention [J ] . Adv Exp Med Biol , 2020 , 1257 : 181 - 192 .
ALEXANDRE J , CAUTELA J , EDERHY S , et al . Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the American and European Cardio-Oncology Guidelines [J ] . J Am Heart Assoc , 2020 , 9 ( 18 ): e018403 .
ANGSUTARARUX P , LUANPITPONG S , ISSARAGRISIL S . Chemotherapy-induced cardiotoxicity:overview of the roles of oxidative stress [J ] . Oxid Med Cell Longev , 2015 : 795602 .
SWAIN SM , WHALEY FS , EWER MS . Congestive heart failure in patients treated with doxorubicin:a retrospective analysis of three trials [J ] . Cancer , 2003 , 97 ( 11 ): 2869 - 2879 .
马力 , 时俊锋 , 童宁 . 紫杉醇类药物的不良反应研究 [J ] . 中国药房 , 2018 , 29 ( 21 ): 3014 - 3017 .
张国霞 , 苏鑫 , 商洪才 , 等 . 从“毒损心络”探析肿瘤心脏病的中医病机 [J ] . 中医杂志 , 2022 , 63 ( 14 ): 1394 - 1396 .
李云芬 , 常莉 , 夏耀雄 , 等 . 左侧乳腺癌放疗相关心脏毒性的危险因素分析 [J ] . 肿瘤防治研究 , 2017 , 44 ( 1 ): 69 - 74 .
MAUREA N , COPPOLA C , PISCOPO G , et al . Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors [J ] . J Cardiovasc Med (Hagerstown) , 2016 , 17 ( S1 ): e19 - e26 .
王文丽 . 毒热证浅析 [J ] . 中医儿科杂志 , 2009 , 5 ( 2 ): 7 - 9 .
ONAITIS M , D'AMICO T , ZHAO Y , et al . Risk factors for atrial fibrillation after lung cancer surgery: analysis of the Society of Thoracic Surgeons general thoracic surgery database [J ] . Ann Thorac Surg , 2010 , 90 ( 2 ): 368 - 374 .
ABDELATTY A , AHMED MS , ABDEL-KAREEM MA , et al . Acute and delayed doxorubicin-induced myocardiotoxicity associated with elevation of cardiac biomarkers,depletion of cellular antioxidant enzymes, and several histopathological and ultrastructural changes [J ] . Life (Basel) , 2021 , 11 ( 9 ): 880 .
李娟 , 石伯伦 , 李玥 , 等 . 调气解毒法调控恶性肿瘤转移前生态位的思路与探析 [J ] . 中医杂志 , 2023 , 64 ( 20 ): 2077 - 2081 .
顾静 . X线诱导心肌成纤维细胞促纤维化损伤及黄芪注射液对其干预的实验研究 [D ] . 兰州 : 兰州大学 , 2014 .
程海波 , 李柳 , 孙东东 , 等 . 抗癌解毒法的建立与应用 [J ] . 中医杂志 , 2022 , 63 ( 15 ): 1420 - 1426 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备 11010102006710号